Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo

Stem Cells and Development

Volumn 18, Issue 7, 2009, Pages 947-953

  Liu, Xuebin ^a   Hou, Jianfeng ^a   Shi, Linhui ^a   Chen, Jinghai ^a   Sang, Jianli ^a   Hu, Shengshou ^a   Cong, Xiangfeng ^a   Chen, Xi ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; LYSOPHOSPHATIDIC ACID; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD31; APOPTOSIS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; FEMALE; LYSOPHOSPHOLIPIDS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL ISCHEMIA; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOPHOSPHATIDIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349200977     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0352     Document Type: Article

References (38)

1. Liu JF, BW Wang, HF Hung, H Chang and KG Shyu. (2008). Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction. J Formos Med Assoc 107:165-174
2. Davani S, A Marandin, N Mersin, B Royer, B Kantelip, P Herve, JP Etievent and JP Kantelip. (2003). Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108(Suppl 1):II253-II258.
3. Suzuki K, RT Smolenski, J Jayakumar, B Murtuza, NJ Brand and MH Yacoub. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102:III216-III221.
4. Muller-Ehmsen J, P Whittaker, RA Kloner, JS Dow, T Sakoda, TI Long, PW Laird and L Kedes. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34:107-116.
5. Yau TM, K Fung, RD Weisel, T Fujii, DA Mickle and RK Li. (2001). Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104:I218-I222.
6. Li RK, ZQ Jia, RD Weisel, F Merante and DA Mickle. (1999). Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 31:513-522.
7. Liu TB, PW Fedak, RD Weisel, T Yasuda, G Kiani, DA Mickle, ZQ Jia and RK Li. (2004). Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation. Am J Physiol Heart Circ Physiol 287:H2840-H2849.
8. Yoshioka T, N Ageyama, H Shibata, T Yasu, Y Misawa, K Takeuchi, K Matsui, K Yamamoto, K Terao, K Shimada, U Ikeda, K Ozawa and Y Hanazono. (2005). Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 23:355-364.
9. Mangi AA, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall and VJ Dzau. (2003). Mesenchymal stem cells modifi ed with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201.
10. Fukuda K and S Yuasa. (2006). Stem cells as a source of regenerative cardiomyocytes. Circ Res 98:1002-1013.
11. Zhang M, D Methot, V Poppa, Y Fujio, K Walsh and CE Murry. (2001). Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33:907-921.
12. Pasha Z, Y Wang, R Sheikh, D Zhang, T Zhao and M Ashraf. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134-142.
13. Gardell SE, AE Dubin and J Chun. (2006). Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med 12:65-75.
14. Meyer zu Heringdorf D and KH Jakobs. (2007). Lysophospholipid receptors: signaling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768:923-940.
15. Zhu W, J Chen, X Cong, S Hu and X Chen. (2006). Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24:416-425.
16. Chen J, AR Baydoun, R Xu, L Deng, X Liu, W Zhu, L Shi, X Cong, S Hu and X Chen. (2008). Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells 26:135-145.
17. Tang YL, Y Tang, YC Zhang, K Qian, L Shen and MI Phillips. (2005). Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46:1339-1350.
18. Muller-Ehmsen J, B Krausgrill, V Burst, K Schenk, UC Neisen, JW Fries, BK Fleischmann, J Hescheler and RH Schwinger. (2006). Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41:876-884.
19. Ohtsuka M, H Takano, Y Zou, H Toko, H Akazawa, Y Qin, M Suzuki, H Hasegawa, H Nakaya and I Komuro. (2004). Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 18:851-853.
20. Shake JG, PJ Gruber, WA Baumgartner, G Senechal, J Meyers, JM Redmond, MF Pittenger and BJ Martin. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73:1919-1925; discussion 1926.
21. Schuleri KH, LC Amado, AJ Boyle, M Centola, AP Saliaris, MR Gutman, KE Hatzistergos, BN Oskouei, JM Zimmet, RG Young, AW Heldman, AC Lardo and JM Hare. (2008). Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294:H2002-H2011.
22. Robey TE, MK Saiget, H Reinecke and CE Murry. (2008). Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45(4):567-581.
23. Hu X, SP Yu, JL Fraser, Z Lu, ME Ogle, JA Wang and L Wei. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135:799-808.
24. Jiang S, H Haider, NM Idris, A Salim and M Ashraf. (2006). Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 99:776-784.
25. Yasuda T, RD Weisel, C Kiani, DA Mickle, M Maganti and RK Li. (2005). Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction. J Thorac Cardiovasc Surg 129:904-911.
26. Nakamura Y, T Yasuda, RD Weisel and RK Li. (2006). Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Am J Physiol Heart Circ Physiol 291:H939-H947.
27. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549.
28. Tang YL, Q Zhao, YC Zhang, L Cheng, M Liu, J Shi, YZ Yang, C Pan, J Ge and MI Phillips. (2004). Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117:3-10.
29. Rivera-Lopez CM, AL Tucker and KR Lynch. (2008). Lysophosphatidic acid (LPA) and angiogenesis. Angiogenesis 11:301-310.
30. Zhang G, J Zhou, Q Fan, Z Zheng, F Zhang, X Liu and S Hu. (2008). Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation. FEBS Lett 582:2957-2964.
31. Al-Khaldi A, N Eliopoulos, D Martineau, L Lejeune, K Lachapelle and J Galipeau. (2003). Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 10:621-629.
32. Laham RJ, J Li, M Tofukuji, M Post, M Simons and FW Sellke. (2003). Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins. Ann Vasc Surg 17:245-252.
33. Sellke FW, SY Wang, A Stamler, JJ Lopez, J Li and M Simons. (1996). Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 271:H713-H720.
34. Uemura R, M Xu, N Ahmad and M Ashraf. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421.
35. Nor JE, J Christensen, DJ Mooney and PJ Polverini. (1999). Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154:375-384.
36. Nagaya N, K Kangawa, T Itoh, T Iwase, S Murakami, Y Miyahara, T Fujii, M Uematsu, H Ohgushi, M Yamagishi, T Tokudome, H Mori, K Miyatake and S Kitamura. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112:1128-1135.
37. Dai W, SL Hale, BJ Martin, JQ Kuang, JS Dow, LE Wold and RA Kloner. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112:214-223.
38. Zhang D, GC Fan, X Zhou, T Zhao, Z Pasha, M Xu, Y Zhu, M Ashraf and Y Wang. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 44:281-292.